GlobeNewsWire
15 Feb 2026, 13:12 UTC · 32w ago
Verdict
Headline leans bearish. We score AQST −0.90.
Score confirms the headline.
Leans bearish
From its wording — no explicit rating
−0.90strongly bearish
Which stocks this story touches
More negative than 88% of ticker scores this week
Stock plunged ~40% after FDA identified deficiencies in its NDA for Anaphylm, raising concerns about approvability.
Continue reading
5 related stories
More negative than 88% of ticker scores this week
Scored by the NIS engine · methodology.
Top 2 movers · tap to explore
Newsfile Corp · 1h ago
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Newsfile Corp
2h ago
+30.1%
Price is moving against the score
$4.75 vs $3.65 close before publication (Feb 13) · not market-adjusted
AQST chart →
